Share Name Share Symbol Market Type Share ISIN Share Description
Abcam Plc LSE:ABC London Ordinary Share GB00B6774699 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -8.00 -0.58% 1,360.00 1,357.00 1,359.00 1,390.00 1,356.00 1,390.00 675,252 16:35:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 260.0 8.4 6.0 226.7 3,084

ABCAM PLC Total Voting Rights

01/03/2021 5:08pm

UK Regulatory (RNS & others)

Abcam (LSE:ABC)
Historical Stock Chart

From Dec 2020 to Jun 2021

Click Here for more Abcam Charts.


RNS Number : 7673Q


01 March 2021

 For immediate release   01 March 2021 


("Abcam" or "Company")

Total Voting Rights - Voting Rights and Capital

In conformity with the Disclosure Rules and Transparency Rules, provision 5.6.1, the Company notifies the market of the following:

The Company's issued share capital consists of 226,719,849 Ordinary Shares of 0.2p each with voting rights. The Company does not hold any shares in Treasury.

The above figure of 226,719,849 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

Date of Notification: 01 March 2021

For further information please contact:

                                                 + 44 (0) 1223 696 
Abcam                                                          000 
Marc Perkins, Company Secretary 
Numis - Nominated Adviser & Joint Corporate       + 44 (0) 20 7260 
 Broker                                                       1000 
Garry Levin / Huw Jeremy 
  J.P.Morgan Cazenove - Joint Corporate Broker     +44 (0) 20 7742 
  James Mitford / Hemant Kapoor                    4000 
  Morgan Stanley - Joint Corporate Broker          +44 (0) 20 425 
  Tom Perry / Luka Kezic                           8000 
  FTI Consulting                                   +44 (0) 20 3727 
  Ben Atwell / Natalie Garland-Collins             1000 

Notes to Editors

About Abcam plc

As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated biological binders and assays to address important targets in critical biological pathways.

Already a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use Abcam's affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences.

By actively listening to and collaborating with researchers, the Company continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results.

Abcam's thirteen locations are in the world's leading life science research hubs, enabling local services and multi-language support. Founded in 1998 and headquartered in Cambridge, UK, the Company sells to more than 100 countries. Abcam was admitted to AIM in 2005 (AIM: ABC).

To find out more, please visit and

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

March 01, 2021 12:08 ET (17:08 GMT)

1 Year Abcam Chart

1 Year Abcam Chart

1 Month Abcam Chart

1 Month Abcam Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210620 06:04:56